Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 94 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| BDKRB2 | ENSG00000168398 | 0.00 | 0.00 | 0 | 0 |
| MLKL | ENSG00000168404 | 0.00 | 0.00 | 0 | 0 |
| MTNR1A | ENSG00000168412 | 0.00 | 0.00 | 0 | 0 |
| KCNG4 | ENSG00000168418 | 0.00 | 0.00 | 0 | 0 |
| KLHL30 | ENSG00000168427 | 0.00 | 0.00 | 0 | 0 |
| TXNDC2 | ENSG00000168454 | 0.00 | 0.00 | 0 | 0 |
| SFTPC | ENSG00000168484 | 0.00 | 0.00 | 0 | 0 |
| BMP1 | ENSG00000168487 | 0.00 | 0.84 | 0 | 5 |
| FEN1 | ENSG00000168496 | 0.13 | 0.00 | 1 | 0 |
| SCGB1D1 | ENSG00000168515 | 0.00 | 0.00 | 0 | 0 |
| ING2 | ENSG00000168556 | 0.00 | 1.26 | 0 | 8 |
| ADAM29 | ENSG00000168594 | 0.00 | 0.00 | 0 | 0 |
| SLC16A4 | ENSG00000168679 | 0.00 | 0.00 | 0 | 0 |
| IL7R | ENSG00000168685 | 0.00 | 0.00 | 0 | 0 |
| WFDC12 | ENSG00000168703 | 0.00 | 0.00 | 0 | 0 |
| IL12A | ENSG00000168811 | 0.00 | 0.00 | 0 | 0 |
| OR13J1 | ENSG00000168828 | 0.00 | 0.00 | 0 | 0 |
| HTR1E | ENSG00000168830 | 0.00 | 0.00 | 0 | 0 |
| USP39 | ENSG00000168883 | 0.26 | 0.00 | 1 | 0 |
| BTNL3 | ENSG00000168903 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 94 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.